Mineralys Therapeutics (MLYS) Interest & Investment Income (2022 - 2026)
Powered by 
Analysis
Mineralys Therapeutics (MLYS) Interest & Investment Income (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Mineralys Therapeutics | 2.39 Bn | 2.39 Bn | - | 4.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.96 Mn |
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 6.05 Mn |
| Sep 30, 2025 | 4.20 Mn |
| Jun 30, 2025 | 3.47 Mn |
| Mar 31, 2025 | 2.24 Mn |
| Dec 31, 2024 | 2.81 Mn |
| Sep 30, 2024 | 3.77 Mn |
| Jun 30, 2024 | 4.15 Mn |
| Mar 31, 2024 | 3.85 Mn |
| Dec 31, 2023 | 3.32 Mn |
| Sep 30, 2023 | 3.51 Mn |
| Jun 30, 2023 | 3.59 Mn |
| Mar 31, 2023 | 2.33 Mn |
| Dec 31, 2022 | 935,000.00 |
| Sep 30, 2022 | 741,000.00 |